In this Issue:
Endocrine and metabolic disorders in ED
Testosterone + tadalafil for ED with testosterone deficiency syndrome
Satisfaction of switching from on demand PDE-5 inhibitor to daily tadalafil
Enclomiphene stimulates serum testosterone within 14 days
Time to clinical improvement with daily tadalafil for LUTS from BPH
Psychological determinants of ED
Low-intensity extracorporeal shockwave therapy for ED
Continuing intracavernosal alprostadil >1 year postradical prostatectomy
No IgE-mediated allergy to semen in POIS
Exogenous testosterone and CV health
Please login below to download this issue (PDF)